DURHAM, N.C.--(BUSINESS WIRE)--Bioventus, a leader in Solutions For Innovative Healing, received authorization to proceed under its investigational new drug (IND) application from the US Food and Drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback